American College of Rheumatology IncPub 78
Pub 78
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$49,791,386
Investments
67%
Property, Plant, & Equipment (net)
14%
Receivables (Non-Related)
8%
Cash & Equivalents
8%
Prepaid Expenses
3%
Related-Party Receivables
0%
Inventories
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$14,014,399
Deferred Revenue
54%
Grants Payable
32%
Payables & Accruals
13%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$5,453,841
$3,999,745
-27%
Receivables (Non-Related)
$2,871,305
$4,042,723
+41%
Related-Party Receivables
-
$0
-
Inventories
-
-
-
Prepaid Expenses
$1,526,403
$1,558,053
+2%
Investments
$34,188,512
$33,423,085
-2%
Property, Plant, & Equipment (net)
$7,223,934
$6,767,780
-6%
Other Assets
-
$0
-
Total Assets
$51,263,995
$49,791,386
-3%
Liabilities
2023
2024
Change
Payables & Accruals
$2,167,922
$1,886,521
-13%
Grants Payable
$6,000,000
$4,500,000
-25%
Deferred Revenue
$7,512,243
$7,627,878
+2%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
$0
-
Other Liabilities
-
$0
-
Total Liabilities
$15,680,165
$14,014,399
-11%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$35,583,830
$35,776,987
+1%
Net assets
2023
2024
Change
Net assets
+$35,583,830
+$35,776,987
+1%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)